MedTrace Logo

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

NCT07060898 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2026-03-06

No results posted yet for this study

Summary

This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.

Conditions

Interventions

DIETARY_SUPPLEMENT

Active Product

Novel Nutritional Product targeting Cognition

DIETARY_SUPPLEMENT

Placebo Product

Identical placebo product

Sponsors & Collaborators

  • Radicle Science (sponsor)

    collaborator UNKNOWN

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Susan Hewlings, PhD · Radicle Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-29
Primary Completion
2025-11-20
Completion
2026-11-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07060898 on ClinicalTrials.gov